651 related articles for article (PubMed ID: 29058144)
1. Rectal Gastrointestinal Stromal Tumor (GIST) in the Era of Imatinib: Organ Preservation and Improved Oncologic Outcome.
Cavnar MJ; Wang L; Balachandran VP; Antonescu CR; Tap WD; Keohan M; Singer S; Temple L; Nash GM; Weiser MR; Guillem JG; Aguilar JG; DeMatteo RP; Paty PB
Ann Surg Oncol; 2017 Dec; 24(13):3972-3980. PubMed ID: 29058144
[TBL] [Abstract][Full Text] [Related]
2. Frequent rectal gastrointestinal stromal tumor recurrences in the imatinib era: Retrospective analysis of an International Patient Registry.
Stuart E; Banerjee S; de la Torre J; Wang Y; Scherzer N; Burgoyne AM; Parry L; Fanta PT; Ramamoorthy S; Sicklick JK
J Surg Oncol; 2019 Sep; 120(4):715-721. PubMed ID: 31297829
[TBL] [Abstract][Full Text] [Related]
3. The effect of neoadjuvant imatinib therapy on outcome and survival in rectal gastrointestinal stromal tumors: A multiinstitutional study.
Yang W; Liu Q; Lin G; Zhang B; Cao H; Zhao Y; Xia L; Feng F; Xiong Z; Hu J; Ye Y; Tao K; Zhang P
J Surg Oncol; 2021 Dec; 124(7):1128-1135. PubMed ID: 34324197
[TBL] [Abstract][Full Text] [Related]
4. Gastrointestinal stromal tumor of the rectum: results of surgical and multimodality therapy in the era of imatinib.
Jakob J; Mussi C; Ronellenfitsch U; Wardelmann E; Negri T; Gronchi A; Hohenberger P
Ann Surg Oncol; 2013 Feb; 20(2):586-92. PubMed ID: 22965573
[TBL] [Abstract][Full Text] [Related]
5. Postoperative imatinib in patients with intermediate risk gastrointestinal stromal tumor.
Wu X; Li J; Xu W; Gao J; Li Y; Shen L
Future Oncol; 2018 Jul; 14(17):1721-1729. PubMed ID: 29969914
[TBL] [Abstract][Full Text] [Related]
6. Comparison of outcomes between neoadjuvant imatinib and upfront surgery in patients with localized rectal GIST: An inverse probability of treatment weighting analysis.
Ling JY; Ding MM; Yang ZF; Zhao YD; Xie XY; Shi LS; Wang HM; Cao WT; Zhang JW; Hu HB; Cai Y; Wang H; Deng YH
J Surg Oncol; 2021 Dec; 124(8):1442-1450. PubMed ID: 34494280
[TBL] [Abstract][Full Text] [Related]
7. Rectal GIST-Outcomes and viewpoint from a tertiary cancer center.
Zanwar S; Ostwal V; Sahu A; Jain D; Ramaswamy A; Saklani A; Ramadwar M; Shetty N; Shrikande SV
Indian J Gastroenterol; 2016 Nov; 35(6):445-449. PubMed ID: 27783353
[TBL] [Abstract][Full Text] [Related]
8. Surgical management of rectal gastrointestinal stromal tumors.
Tielen R; Verhoef C; van Coevorden F; Reyners AK; van der Graaf WT; Bonenkamp JJ; van Etten B; de Wilt JH
J Surg Oncol; 2013 Mar; 107(4):320-3. PubMed ID: 22806955
[TBL] [Abstract][Full Text] [Related]
9. Assessing prognostic factors of long-term survival after surgery for colorectal gastrointestinal stromal tumours.
Yang S; Maspero M; Holubar SD; Hull TL; Lightner AL; Valente MA; Gorgun E; Kalady MF; Steele SR; Liska D
Colorectal Dis; 2023 Dec; 25(12):2325-2334. PubMed ID: 37876119
[TBL] [Abstract][Full Text] [Related]
10. [A Case of Rectal Gastrointestinal Stromal Tumor(GIST)Treated with Imatinib Mesylate Neoadjuvant Therapy to Preserve the Anus].
Kenno S; Inagaki M; Funakoshi T; Yanagida N; Akabane H; Nakano S; Sato K
Gan To Kagaku Ryoho; 2018 Jun; 45(6):981-984. PubMed ID: 30026427
[TBL] [Abstract][Full Text] [Related]
11. Outcome of 1000 Patients With Gastrointestinal Stromal Tumor (GIST) Treated by Surgery in the Pre- and Post-imatinib Eras.
Cavnar MJ; Seier K; Curtin C; Balachandran VP; Coit DG; Yoon SS; Crago AM; Strong VE; Tap WD; Gönen M; Antonescu CR; Brennan MF; Singer S; DeMatteo RP
Ann Surg; 2021 Jan; 273(1):128-138. PubMed ID: 30946076
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant imatinib in locally advanced gastrointestinal stromal tumors (GIST): the EORTC STBSG experience.
Rutkowski P; Gronchi A; Hohenberger P; Bonvalot S; Schöffski P; Bauer S; Fumagalli E; Nyckowski P; Nguyen BP; Kerst JM; Fiore M; Bylina E; Hoiczyk M; Cats A; Casali PG; Le Cesne A; Treckmann J; Stoeckle E; de Wilt JH; Sleijfer S; Tielen R; van der Graaf W; Verhoef C; van Coevorden F
Ann Surg Oncol; 2013 Sep; 20(9):2937-43. PubMed ID: 23760587
[TBL] [Abstract][Full Text] [Related]
13. Preoperative Chemotherapy and Survival for Large Anorectal Gastrointestinal Stromal Tumors: A National Analysis of 333 Cases.
Hawkins AT; Wells KO; Krishnamurty DM; Hunt SR; Mutch MG; Glasgow SC; Wise PE; Silviera ML
Ann Surg Oncol; 2017 May; 24(5):1195-1201. PubMed ID: 28050726
[TBL] [Abstract][Full Text] [Related]
14. Role of surgery in patients with recurrent, metastatic, or unresectable locally advanced gastrointestinal stromal tumors sensitive to imatinib: a retrospective analysis of the Spanish Group for Research on Sarcoma (GEIS).
Rubió-Casadevall J; Martinez-Trufero J; Garcia-Albeniz X; Calabuig S; Lopez-Pousa A; Del Muro JG; Fra J; Redondo A; Lainez N; Poveda A; Valverde C; De Juan A; Sevilla I; Casado A; Andres R; Cruz J; Martin-Broto J; Maurel J;
Ann Surg Oncol; 2015 Sep; 22(9):2948-57. PubMed ID: 25608769
[TBL] [Abstract][Full Text] [Related]
15. Long-term survival outcome with tyrosine kinase inhibitors and surgical intervention in patients with metastatic or recurrent gastrointestinal stromal tumors: A 14-year, single-center experience.
Kim JH; Ryu MH; Yoo C; Chae H; Na H; Beck M; Kim BS; Yoo MW; Yook JH; Kim BS; Kim KH; Kim CW; Kang YK
Cancer Med; 2019 Mar; 8(3):1034-1043. PubMed ID: 30693663
[TBL] [Abstract][Full Text] [Related]
16. The effect of neoadjuvant Imatinib therapy on outcome and survival after rectal gastrointestinal stromal tumour.
Machlenkin S; Pinsk I; Tulchinsky H; Ziv Y; Sayfan J; Duek D; Rabau M; Walfisch S
Colorectal Dis; 2011 Oct; 13(10):1110-5. PubMed ID: 21040362
[TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant Imatinib Therapy Followed by Intersphincteric Resection for Low Rectal Gastrointestinal Stromal Tumors.
Kaneko M; Nozawa H; Emoto S; Murono K; Sasaki K; Otani K; Nishikawa T; Tanaka T; Kiyomatsu T; Hata K; Kawai K; Watanabe T
Anticancer Res; 2017 Sep; 37(9):5155-5160. PubMed ID: 28870948
[TBL] [Abstract][Full Text] [Related]
18. Open transanal resection of low rectal stromal tumor following neoadjuvant therapy of imatinib mesylate: Report of 11 cases and review of literature.
Sun Q; Su N; Li X; Hu Z; Wang W
Asia Pac J Clin Oncol; 2020 Jun; 16(3):123-128. PubMed ID: 31957191
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant imatinib treatment and laparoscopic anus-preserving surgery for a large gastrointestinal stromal tumor of the rectum.
Kyo K; Azuma M; Okamoto K; Nishiyama M; Shimamura T; Maema A; Kanamaru H; Shirakawa M; Nakamura T; Shinmura K; Koda K; Yokoyama H
World J Surg Oncol; 2016 Mar; 14():68. PubMed ID: 26957123
[TBL] [Abstract][Full Text] [Related]
20. A long-term follow-up of the imatinib mesylate treatment for the patients with recurrent gastrointestinal stromal tumor (GIST): the liver metastasis and the outcome.
Zhu J; Yang Y; Zhou L; Jiang M; Hou M
BMC Cancer; 2010 May; 10():199. PubMed ID: 20465813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]